Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PSA doubling time and method of calculation].

Alain Ruffion1, Xavier Rebillard, François Grima

  • 1Service d'Urologie, Hôpital de Lyon Sud, Pierre Bénite, France. alain.ruffion@chu-lyon.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|January 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic Screening of Occupational Exposures in patients with prostate or kidney cancer.

The French journal of urology·2026
Same author

Prospective registry for patients undergoing artificial urinary sphincter surgery for female stress urinary incontinence due to intrinsic sphincter deficiency: Study protocol.

The French journal of urology·2026
Same author

Outcomes of inguinal hernia repair after implantation of preperitoneal reservoir for artificial urinary sphincter or penile implant.

BMC surgery·2026
Same author

Assessing the adequacy of funding for robotic-surgery hospital stays: a focused cost analysis based on 1,722 procedures in a French university hospital.

Journal of robotic surgery·2026
Same author

Long-term sexual outcomes in classic bladder exstrophy: Insights from standardized scores.

Journal of pediatric urology·2026
Same author

Penis "En Bloc": From Reproducible Harvesting to Transplantation in a Cadaver study.

European urology open science·2026

Prostate Specific Antigen (PSA) kinetic, particularly PSA doubling time, offers valuable insights beyond absolute levels for prostate cancer management. This marker aids in surveillance, prognosis, and treatment evaluation across various clinical scenarios.

Area of Science:

  • Oncology
  • Biochemistry
  • Urology

Context:

  • Prostate Specific Antigen (PSA) is the primary biomarker for prostate cancer but lacks specificity.
  • PSA kinetics, including PSA doubling time, presents a promising avenue for enhancing diagnostic and prognostic accuracy.
  • Understanding PSA kinetic patterns is crucial for optimizing prostate cancer patient management.

Purpose:

  • To review methods for studying PSA kinetics, focusing on the PSA doubling time.
  • To explore the clinical utility of PSA doubling time in diverse prostate cancer scenarios.
  • To provide a comprehensive overview of PSA kinetic analysis in prostate cancer.

Summary:

  • The review details methodologies for assessing PSA kinetics, highlighting PSA doubling time as a reliable parameter.

Related Experiment Videos

  • It outlines the calculation methods for PSA doubling time.
  • The paper discusses the application of PSA doubling time in surveillance, prognosis, and treatment evaluation for prostate cancer.

    • Impact:

    • PSA doubling time can serve as a prognostic factor for tumor aggressiveness and treatment efficacy.
    • Its application spans from post-diagnosis surveillance to evaluating outcomes after curative treatment and during endocrine therapy.
    • This kinetic marker enhances the clinical utility of PSA testing in managing prostate cancer patients.